GRID and Lattice Radiotherapy for Very Large Tumours — What It Is and Who It Is For

Spatially fractionated radiation therapy deliberately gives an uneven dose. Instead of coating a tumour evenly, the beam is broken into a pattern of small high-dose islands with low-dose gaps between them. GRID does this in two dimensions, like light through a sieve. Lattice does it in three, as a grid of dose spheres inside the mass.

Conventional radiotherapy aims for the opposite: a uniform dose across the whole target, kept under the limit that the healthy tissue around it can tolerate. That works well until the mass is very large. With a bulky tumour, the dose needed to make a real difference is often more than the surrounding skin, bowel, lung or nerve can safely absorb — so the plan gets scaled down, and the treatment ends up limited by the neighbours rather than by the tumour.

Spatially fractionated radiation therapy, usually shortened to SFRT, sidesteps that trade-off. Because the high-dose islands are small and separated, the tissue in the valleys between them is largely spared and helps repair the region afterwards. That is what allows a far higher peak dose inside the tumour than a uniform plan would ever permit.

There is a second, less obvious reason radiation oncologists find it interesting. The steep switch between peak and valley appears to set off signalling between irradiated and non-irradiated cells — described in the literature as bystander and abscopal effects — and there is active research into whether that adds to the direct effect of the dose. That research is ongoing, not settled.

Your radiotherapy is delivered at an NABH-accredited partner centre; CION Cancer Clinics coordinates your treatment plan, your oncology team and your care throughout. CION does not own or operate a linear accelerator, a CyberKnife, a Gamma Knife or any other radiotherapy machine.

It is used when a tumour is too bulky for a standard uniform plan. That usually means a large mass pressing on something, causing pain, bleeding or obstruction, where a full uniform dose would exceed what the nearby tissue can tolerate. The goal is most often to reduce the bulk and relieve symptoms, sometimes to make further treatment possible.

This is the part families are rarely told. When a mass is described as too large to irradiate properly, that is a statement about the uniform plan, not about radiation itself. Spatially fractionated approaches exist for exactly that situation, and they have been reported in bulky sarcomas, large head and neck masses, bulky nodal disease, some lung and abdominal masses, and painful or fungating tumours where comfort is the priority.

• The mass is bulky and symptomatic — it is causing pain, pressure, bleeding, obstruction or an open wound, and something needs to change quickly.
• A uniform plan would over-dose the neighbours — bowel, skin, spinal cord, lung or a nerve sits too close for the dose the tumour would need.
• The intent is control and comfort — reducing bulk and relieving symptoms is a legitimate treatment goal in its own right, not a lesser one.
• The area may have been irradiated before — re-treatment is one of the situations where sparing the tissue between dose islands matters most.
• It is usually a first step, not the whole plan — a high-dose session is generally followed by a conventional course, and coordinated with whatever systemic treatment your medical oncologist advises.
• It is decided at a tumour board, not on a website — size, site, prior treatment and your general condition all have to be weighed together.

Nothing on this page is a recommendation for your case. It exists so that you know the option is real and can ask about it by name.

In reported use it has been well tolerated, but the evidence base is small. Because the tissue between the high-dose islands is spared, published series describe side effects broadly similar to conventional radiation to the same area. What is missing is large randomised trial data, which is why it sits outside routine guideline recommendations.

The safety logic is structural rather than hopeful. A very high dose is only allowed to exist in small, separated volumes, and the untouched tissue in the valleys is what carries the region through afterwards. That is the same reasoning that made sieve therapy work with early machines, and it is why the plan is built by a medical physicist with the peak-to-valley ratio calculated in advance rather than estimated.

The risks are the familiar ones for radiation to that part of the body — skin reaction, fatigue, swelling in and around the treated area, and site-specific effects such as soreness on swallowing for a neck mass or bowel irritation for an abdominal one. Where a bulky tumour responds quickly there is also a small risk of bleeding, or of a cavity forming as the mass reduces, which is one reason the first session is followed closely.

What no one can promise you is a result. A team that talks about this in certainties is overselling it. The honest framing, as of August 2026, is that spatially fractionated radiation is a recognised technique with a long history and a growing but still limited evidence base, and that ASTRO-supported working groups are gathering that evidence now.

Dose limits, long-term effects and second-cancer risk should be discussed against your own plan and your own treatment history. Ask your radiation oncologist to show you the planned dose to each organ at risk.

• Is the tumour too large for a uniform plan, or too large for radiation altogether? — these are two different statements, and only the second closes the door.
• Which organ at risk is limiting my dose, and by how much? — ask to see the planned numbers, not a summary of them.
• Has spatially fractionated radiation been considered for this mass? — naming GRID or lattice specifically usually gets a specific answer.
• What would the goal realistically be — symptom relief, reducing bulk, or enabling further treatment? — agree the goal before agreeing the technique.
• How many sessions in total, and how many trips to the centre? — for a frail patient this often matters more than anything else on the list.
• Can I have a written, itemised estimate? — indicative only, as of August 2026, but get planning, delivery and follow-up separated out.

• If what caught your attention was the idea of an unusual dose rate rather than an unusual dose pattern, that is a different technique entirely — FLASH Radiotherapy: What It Is and Whether You Can Get It sets out where it currently stands.
• At the opposite end of the size question, some treatments have to cover a very wide, very shallow area rather than one bulky mass — see Total Skin Electron Beam Therapy for Skin Lymphoma.
• For small, shallow lesions the answer is usually a low-energy beam rather than a shaped one: Superficial and Orthovoltage X-Ray Therapy for Skin Lesions explains when that is used.
• And where the whole body has to be treated as the target, the planning problem inverts again — Total Body Irradiation Before a Bone Marrow Transplant covers that setting.
• For the full picture of how radiation is planned, delivered and coordinated with NABH-accredited partner centres, start at Radiation Therapy at CION Cancer Clinics.

Still not sure whether this applies to your own scan? Book a free consultation and a radiation oncologist will go through the reports with you directly, or call 1800 202 8726.